Back to funds

BVF INC/IL

Updated 6 days ago

Managed by Bvf Inc/Il • Latest filing Q3 2026

Portfolio value
$3B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$3B
Q1 2026$3.1B
Q2 2026$3.9B
Q3 2026$3B

Top holdings

47 positions as of Q3 2026

View filing
R

REVOLUTION MEDICINES INC

Value
$505.1M
Shares
2.46M
% Port
16.61%
K

KYMERA THERAPEUTICS INC

Value
$432.9M
Shares
3.87M
% Port
14.24%
G

GH RESEARCH PLC

Value
$203.1M
Shares
8.65M
% Port
6.68%
M

MOONLAKE IMMUNOTHERAPEUTICS

Value
$187.2M
Shares
16.00M
% Port
6.16%
X

XENCOR INC

Value
$155.4M
Shares
6.23M
% Port
5.11%
N

NEKTAR THERAPEUTICS

Value
$129.2M
Shares
2.13M
% Port
4.25%
A

ALKERMES PLC

Value
$115.4M
Shares
2.85M
% Port
3.79%
S

STOKE THERAPEUTICS INC

Value
$93.8M
Shares
3.61M
% Port
3.09%
T

TYRA BIOSCIENCES INC

Value
$92.2M
Shares
4.22M
% Port
3.03%
Z

ZYMEWORKS INC

Value
$91.8M
Shares
3.46M
% Port
3.02%
C

CULLINAN THERAPEUTICS INC

Value
$88.3M
Shares
5.75M
% Port
2.90%
G

STRUCTURE THERAPEUTICS INC

Value
$84.2M
Shares
2.69M
% Port
2.77%
P

PALVELLA THERAPEUTICS INC NE

Value
$83.7M
Shares
607.1K
% Port
2.75%
K

KURA ONCOLOGY INC

Value
$71.7M
Shares
6.69M
% Port
2.36%
A

AC IMMUNE SA

Value
$51.9M
Shares
19.82M
% Port
1.71%
M

MONTE ROSA THERAPEUTICS INC

Value
$51M
Shares
4.28M
% Port
1.68%
E

ENTERA BIO LTD

Value
$49.6M
Shares
17.05M
% Port
1.63%
O

OLEMA PHARMACEUTICALS INC

Value
$45.8M
Shares
5.30M
% Port
1.51%
C

CRESCENT BIOPHARMA INC.

Value
$45.1M
Shares
3.09M
% Port
1.48%
F

4D MOLECULAR THERAPEUTICS IN

Value
$41.2M
Shares
2.88M
% Port
1.36%

Explore